Dr. Dewi F. Cabacar

William D. Gaillard, MD, professor of neurology and neurophysiology, is chief of the Divisions of Child Neurology and of Epilepsy and Neurophysiology. He is director of the Comprehensive Pediatric Epilepsy Program — one of the leading multidisciplinary pediatric epilepsy programs in the country. As associate director of the Children’s National Research Institute’s Center for Neuroscience Research, he is responsible for overseeing and organizing clinical neuroscience research. Dr. Gaillard is professor of pediatrics and neurology at the George Washington University School of Medicine; Professor of Neurology, Georgetown University; and Adjunct Professor of Hearing and Speech Sciences, University of Maryland, College Park. Additionally, Dr. Gaillard holds longstanding collaborations with the Clinical Epilepsy Section (CES), National Institute of Neurological Disorders and Stroke and NIH. His innovative research utilizes advanced structural and functional imaging to examine the effects of epilepsy on brain structure and function. His pioneering work with functional imaging has changed clinical practice for patients with epilepsy, made important technical contributions to structural and functional imaging methods, and provided fundamental scientific insights on the biology of brain plasticity. Ultimately, the goal of his research is to improve the outcomes and lives of children with epilepsy. Dr. Gaillard is a past president of the American Epilepsy Society. He is past treasurer of the American Epilepsy Society, past chair of the International League Against Epilepsy (ILAE) Commission on Diagnostics, past chair of the ILAE Pediatric Epilepsy Surgery Task Force and past member of the Pediatric Commission. He is a past editor of Epilepsy Research and a past editor of Epilepsia. He is the author of more than 240 peer-reviewed scientific papers and more than 50 chapters and holds longstanding federal and foundation grant funding. Dr. Gaillard is highly rated in 28 conditions, according to our data. His clinical expertise encompasses Epilepsy, Seizures, Status Epilepticus, Liver Embolization, and Deep Brain Stimulation. Dr. Gaillard is board certified in American Board Of Psychiatry And Neurology, Pediatrics: American Board Of Pediatrics, 2005, and American Board Of Psychiatry And Neurology, 1992.

Tammy Tsuchida, MD, PhD, is a professor in the departments of Neurology and Pediatrics at the George Washington University School of Medicine and Health Sciences. She completed her fellowships in child neurology and neurophysiology at the University of California, San Francisco, after finishing medical school at Columbia University Vagelos College of Physicians and Surgeons in 1997. At Children's National Hospital, she is a co-director of the Hemimegalencephaly (HME) Program. She consults and teaches in the Neonatal Neurocritical Care Program and Comprehensive Pediatric Epilepsy Program. Her areas of interest are the study and clinical care of neonates and infants with brain injury, seizures and epilepsy as well as neonatal electroencephalogram (EEG). Dr. Tsuchida has made significant contributions to national EEG guidelines and international recommendations for managing neonatal seizures and epilepsy. Dr. Tsuchida is highly rated in 11 conditions, according to our data. Her clinical expertise encompasses Epilepsy in Children, Hemimegalencephaly, Seizures, Epilepsy, and Liver Embolization. Dr. Tsuchida is board certified in Epilepsy: American Board Of Psychiatry And Neurology, 2018, Clinical Neurophysiology: American Board Of Psychiatry And Neurology, 2009, and American Board Of Psychiatry And Neurology, 2003.

Dr. Comi graduated from SUNY Buffalo School of Medicine and received her training in pediatrics at the Children's Hospital of Buffalo and her child neurology training at Johns Hopkins Medicine. Her clinical specialization is in the treatment of the neurological aspects of Sturge-Weber syndrome and other disorders related to capillary malformation. Dr. Comi's clinical research interests focus on improving the early diagnosis and treatment of brain involvement in Sturge-Weber syndrome in order to prevent ischemic brain injury in affected infants and young children, and on studies to understand what causes Sturge-Weber syndrome. Her laboratory research work deals with the pathogenesis of Sturge-Weber syndrome, recently shown to be caused by a somatic mutation, and on developing new drug targets, screening assays, models and therapeutic strategies for Sturge-Weber syndrome. Her lab group also works on developing better neuroprotective and neuroregenerative responses to brain injury resulting from impaired blood flow to the brain. Dr. Comi is highly rated in 24 conditions, according to our data. Her clinical expertise encompasses Sturge-Weber Syndrome, Parkes Weber Syndrome, Stork Bite, Epilepsy in Children, and Endovascular Embolization. Dr. Comi is board certified in American Board Of Psychiatry And Neurology.